Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Exploring Acute Neuroplasticity in Depression using Repetitive Transcranial Magnetic Stimulation for Comorbidities
EF 2023-24
Résumé
Major depressive disorder (MDD) is a debilitating disorder that has been ranked the single largest contributor to global disability. A subset of individuals suffering from MDD have treatment-resistant depression and do not respond to conventional antidepressants or psychotherapy. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive, brain stimulation therapy approved for treatment-resistant MDD. MDD is frequently co-morbid with diabetes mellitus (DM), and dysregulated blood sugar (glucose) control in DM may impair neuroplasticity induced by rTMS, possibly through cerebrovascular and metabolic pathways. The objective of this study is to use advanced neuroimaging methods that use concurrent (interleaved) rTMS and functional magnetic resonance imaging (fMRI) in MDD to examine how markers of glucose regulation, pre-DM and DM status are associated with (i) clinical response to rTMS treatment and (ii) neuroplastic response to rTMS. This research intends to advance our knowledge of the relationships between MDD, glucose control and their combined effects on neuroplasticity and clinical outcomes (mood and cognition) following rTMS therapy. If successful, the proposed work will provide novel insights into mechanisms of impaired brain plasticity and therapeutic response to rTMS when DM and MDD are co-morbid, and these findings could inform new approaches to optimize rTMS with adjunctive glucose control therapies in MDD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506205
Name
Silver Dara R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring Acute Neuroplasticity in Depression using Repetitive Transcranial Magnetic Stimulation for Comorbidities
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Imaging; Brain Stimulation; Depression; Diabetes; Fmri; Mental Health; Neuroimaging; Neuromodulation; Tms/Rtms; Transcranial
Abstract
Major depressive disorder (MDD) is a debilitating disorder that has been ranked the single largest contributor to global disability. A subset of individuals suffering from MDD have treatment-resistant depression and do not respond to conventional antidepressants or psychotherapy. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive, brain stimulation therapy approved for treatment-resistant MDD. MDD is frequently co-morbid with diabetes mellitus (DM), and dysregulated blood sugar (glucose) control in DM may impair neuroplasticity induced by rTMS, possibly through cerebrovascular and metabolic pathways. The objective of this study is to use advanced neuroimaging methods that use concurrent (interleaved) rTMS and functional magnetic resonance imaging (fMRI) in MDD to examine how markers of glucose regulation, pre-DM and DM status are associated with (i) clinical response to rTMS treatment and (ii) neuroplastic response to rTMS. This research intends to advance our knowledge of the relationships between MDD, glucose control and their combined effects on neuroplasticity and clinical outcomes (mood and cognition) following rTMS therapy. If successful, the proposed work will provide novel insights into mechanisms of impaired brain plasticity and therapeutic response to rTMS when DM and MDD are co-morbid, and these findings could inform new approaches to optimize rTMS with adjunctive glucose control therapies in MDD.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Silver, Dara R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~